SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
{{output}}
Targeting the interaction between the SARS-CoV-2 spike protein and human ACE2, its primary cell membrane receptor, is a promising therapeutic strategy to prevent viral entry. Recent in vitro studies revealed that the receptor binding domain (RBD) of the spike ... ...
